Skip to content
healthcare.dev
Get a free key

Phesgo

NDC 50242-245, pertuzumab, trastuzumab, and hyaluronidase-zzxf, injection, solution, from Genentech, Inc..

Product NDC
50242-245
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761170
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-245 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PERTUZUMAB1200 mg/15mL
  • TRASTUZUMAB600 mg/15mL
  • HYALURONIDASE (HUMAN RECOMBINANT)30000 U/15mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; HER2/Neu/cerbB2 Antagonists [MoA]; HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package
50242-245-01502420245011 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE
50242-245-86502420245861 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) / 15 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/27dd5e6b-72cd-458d-a015-cf4dab5800da

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-245

Use it

Look up 50242-245 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-245 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.